November 29, 2016 / 9:20 PM / a year ago

BRIEF-Valeant announces initiation of a primary care sales force for Xifaxan and Relistor

Nov 29 (Reuters) - Valeant Pharmaceuticals International Inc

* Valeant announces the initiation of a primary care sales force for Xifaxan and Relistor

* Says costs of program were considered in previously announced guidance for full year 2016 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below